DANIEL NEFF: Open Payments
NPI 1811315872 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$607 in 23 payments from 7 companies in 2025. Trend: 2023 $161 · 2024 $299 · 2025 $607
Food & beverage: $457Honoraria: $150
| Company | Payments | Amount |
|---|---|---|
| H2-Pharma, LLC | 1 | $150 |
| Braeburn Inc. | 6 | $139 |
| ABBVIE INC. | 6 | $101 |
| E.R. Squibb & Sons, L.L.C. | 5 | $91 |
| Indivior Inc. | 3 | $76 |
| Alkermes, Inc. | 1 | $34 |
| Vanda Pharmaceuticals Inc. | 1 | $16 |
Products named: BRIXADI, VRAYLAR, COBENFY, SUBLOCADE, VIVITROL, FANAPT.
Industry payments across PA — which companies pay providers there.
